Multimodal Quantified Analysis of Facial Movements: Comparison Between Pathological and Control Subjects
AQ2MF
1 other identifier
interventional
720
1 country
1
Brief Summary
The facial palsy is a frequent disease with a lot of etiologies. It has variable severities with sometimes heavy functional repercussions and different recovery potentials. The proposed treatments are based on surgery, physiotherapy and botulinum toxin injections. However, when recovery is incomplete, acceptance is more difficult, with an impacted quality of life. Thanks to Motion Capture and Electromyography, a quantification of the facial mimicry is now possible with a great precision. In addition with the quantification of the facial mimicry, eye-tracking, wich is widely used in the marketing field, but it also finds medical applications including head and neck lesions and facial palsy in particular, will be used to evaluate the visio of the patients on their pathology in function of the movement quantification measured with MoCap and Electromyography. The aim of this research is to measure in a combined way the action potentials by sEMG and the amplitudes of displacement of the markers in motion capture, for movements determined in a population of patients presenting a facial pathology, in order to compare them with reference values obtained in healthy subjects. In a second step, the aim will be to study if there is a link between the way the patient looks at his pathology and the results of his management (treatment, rehabilitation) which will be quantitatively evaluated thanks to MoCap and sEMG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2022
CompletedStudy Start
First participant enrolled
October 12, 2022
CompletedFirst Posted
Study publicly available on registry
October 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
May 28, 2025
May 1, 2025
5 years
October 12, 2022
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
determination of baseline values of facial mimicry (in millimetres) in healthy volunteers
determination of baseline values of facial mimicry (in millimetres) in healthy volunteers
one month
determination of baseline values of eye-tracking (in millimetres) in healthy volunteers
determination of baseline values of eye-tracking (in millimetres) in healthy volunteers
one month
determination of the maximum range of motion of facial mimicry (in millimetres) in patients
determination of the maximum range of motion facial mimicry (in millimetres) in patients
one year
determination of the maximum range of motion of eye-tracking (in millimetres) in patients
determination of the maximum range of motion of eye-tracking (in millimetres) in patients
one year
Study Arms (2)
patients with facial palsy
EXPERIMENTALhealthy volunteers
ACTIVE COMPARATORInterventions
Simultaneous MoCap and EMG acquisition
Eye-tracking acquisition for pathological subjects
Follow-up visit for pathological subjects
Eligibility Criteria
You may qualify if:
- Subjects with no known facial pathology (healthy volunteers) OR
- Patients with peripheral facial palsy, irrespective of grade, whether or not previously treated
- Subject with written informed consent
- Subject over 18 years of age
- Subject affiliated to a social security scheme
You may not qualify if:
- Subjects with severe skin disorders that do not allow the application of electrodes or photo reflective markers
- Subjects with speech disorders making it impossible to pronounce the sounds \[o\] and \[pu\]
- Subject unable to provide written informed consent
- Subjects under guardianship, curators or safeguard of justice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens Picardie
Amiens, Picardie, 80054, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2022
First Posted
October 14, 2022
Study Start
October 12, 2022
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2028
Last Updated
May 28, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share